Maletzki C - Search Results

1

Knockdown of coagulation factor VII has potential anticoagulant and anti-inflammatory effects in a mouse model of group A streptococcal sepsis.

Köhler J, Maletzki C, Revenko AS, Mikkat S, Kreikemeyer B, Oehmcke-Hecht S. Köhler J, et al. Among authors: maletzki c. Microbes Infect. 2023 Nov-Dec;25(8):105178. doi: 10.1016/j.micinf.2023.105178. Epub 2023 Jun 29. Microbes Infect. 2023. PMID: 37392986 Free article.

2

Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model.

Maletzki C, Linnebacher M, Kreikemeyer B, Emmrich J. Maletzki C, et al. Gut. 2008 Apr;57(4):483-91. doi: 10.1136/gut.2007.125419. Epub 2007 Nov 19. Gut. 2008. PMID: 18025068

3

Lysates of S. pyogenes serotype M49 induce pancreatic tumor growth delay by specific and unspecific antitumor immune responses.

Linnebacher M, Maletzki C, Emmrich J, Kreikemeyer B. Linnebacher M, et al. Among authors: maletzki c. J Immunother. 2008 Oct;31(8):704-13. doi: 10.1097/CJI.0b013e3181829f62. J Immunother. 2008. PMID: 18779749

4

Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis.

Zautner AE, Krause M, Stropahl G, Holtfreter S, Frickmann H, Maletzki C, Kreikemeyer B, Pau HW, Podbielski A. Zautner AE, et al. Among authors: maletzki c. PLoS One. 2010 Mar 1;5(3):e9452. doi: 10.1371/journal.pone.0009452. PLoS One. 2010. PMID: 20209109 Free PMC article.

5

Avitalized bacteria mediate tumor growth control via activation of innate immunity.

Klier U, Maletzki C, Göttmann N, Kreikemeyer B, Linnebacher M. Klier U, et al. Among authors: maletzki c. Cell Immunol. 2011;269(2):120-7. doi: 10.1016/j.cellimm.2011.03.014. Epub 2011 Mar 17. Cell Immunol. 2011. PMID: 21463858

6

Combining bacterial-immunotherapy with therapeutic antibodies: a novel therapeutic concept.

Klier U, Maletzki C, Kreikemeyer B, Klar E, Linnebacher M. Klier U, et al. Among authors: maletzki c. Vaccine. 2012 Apr 5;30(17):2786-94. doi: 10.1016/j.vaccine.2012.01.071. Epub 2012 Feb 13. Vaccine. 2012. PMID: 22342917

7

Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's Toxin.

Maletzki C, Klier U, Obst W, Kreikemeyer B, Linnebacher M. Maletzki C, et al. Clin Dev Immunol. 2012;2012:230625. doi: 10.1155/2012/230625. Epub 2012 Nov 11. Clin Dev Immunol. 2012. PMID: 23193416 Free PMC article.

8

Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.

Fiedler T, Strauss M, Hering S, Redanz U, William D, Rosche Y, Classen CF, Kreikemeyer B, Linnebacher M, Maletzki C. Fiedler T, et al. Among authors: maletzki c. Cancer Biol Ther. 2015;16(7):1047-55. doi: 10.1080/15384047.2015.1026478. Epub 2015 Mar 16. Cancer Biol Ther. 2015. PMID: 25774632 Free PMC article.

9

Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas.

Maletzki C, Rosche Y, Riess C, Scholz A, William D, Classen CF, Kreikemeyer B, Linnebacher M, Fiedler T. Maletzki C, et al. Chem Biol Interact. 2017 Dec 25;278:179-188. doi: 10.1016/j.cbi.2017.10.007. Epub 2017 Oct 5. Chem Biol Interact. 2017. PMID: 28989041

10

Arginine-Depleting Enzymes - An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies.

Riess C, Shokraie F, Classen CF, Kreikemeyer B, Fiedler T, Junghanss C, Maletzki C. Riess C, et al. Among authors: maletzki c. Cell Physiol Biochem. 2018;51(2):854-870. doi: 10.1159/000495382. Epub 2018 Nov 22. Cell Physiol Biochem. 2018. PMID: 30466103 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters